Linking miR-138 and USP10-P53 signaling
Linking miR-138 and USP10-P53 signaling |
|
https://doi.org/10.18632/oncotarget.27260
Ri Cui
|
| 6541-6542 |
Targeting phosphatases in cancer: suppression of many versus the ablation of one
Targeting phosphatases in cancer: suppression of many versus the ablation of one |
|
https://doi.org/10.18632/oncotarget.27201
Brandon M. D’Arcy,
Aishwarya Prakash,
and Richard E. Honkanen
|
| 6543-6545 |
Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment
Evaluation of a ConvitVax/anti-PD-1 combined immunotherapy for breast cancer treatment |
|
https://doi.org/10.18632/oncotarget.27283
María José Godoy-Calderón,
Eglys González-Marcano,
Jeismar Carballo,
and Ana Federica Convit
|
| 6546-6560 |
The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44
The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44 |
|
https://doi.org/10.18632/oncotarget.27302
Chunmei Zhao,
Benjamin J. Thompson,
Kelly Chen,
Feng Gao,
Barbara Blouw,
Mathieu Marella,
Susan Zimmerman,
Trevor Kimbler,
Sheryl Garrovillo,
Jesse Bahn,
Lei Huang,
Zhongdong Huang,
H. Michael Shepard,
Sanna Rosengren,
Christopher D. Thanos,
and Daniel C. Maneval
|
| 6561-6576 |
High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target
High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target |
|
https://doi.org/10.18632/oncotarget.27312
Guilhem Bousquet,
Jean-Paul Feugeas,
Yuchen Gu,
Christophe Leboeuf,
Morad El Bouchtaoui,
He Lu,
Marc Espié,
Anne Janin,
and Melanie Di Benedetto
|
| 6577-6588 |
The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer
The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer |
|
https://doi.org/10.18632/oncotarget.27284
Ana Emília Goulart Lemos,
Aline da Rocha Matos,
Luciana Bueno Ferreira,
and Etel Rodrigues Pereira Gimba
|
| 6589-6603 |
Tumor mutational burden in lung cancer: a systematic literature review
Tumor mutational burden in lung cancer: a systematic literature review |
|
https://doi.org/10.18632/oncotarget.27287
Connor Willis,
Michelle Fiander,
Dao Tran,
Beata Korytowsky,
John-Michael Thomas,
Florencio Calderon,
Teresa M. Zyczynski,
Diana Brixner,
and David D. Stenehjem
|
| 6604-6622 |
The multifaceted anti-cancer effects of BRAF-inhibitors
The multifaceted anti-cancer effects of BRAF-inhibitors |
|
https://doi.org/10.18632/oncotarget.27304
Laura Croce,
Francesca Coperchini,
Flavia Magri,
Luca Chiovato,
and Mario Rotondi
|
| 6623-6640 |
Correction: The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia
Correction: The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.27310
Xia Li,
Xiufeng Yin,
Huafeng Wang,
Jiansong Huang,
Mengxia Yu,
Zhixin Ma,
Chenying Li,
Yile Zhou,
Xiao Yan,
ShuJuan Huang,
and Jie Jin
|
| 6641-6642 |
Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells
Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells |
|
https://doi.org/10.18632/oncotarget.27314
Ana Fernandez-Carrascal,
Manuel Garcia-Algar,
Moritz Nazarenus,
Alicia Torres-Nuñez,
Luca Guerrini,
Neus Feliu,
Wolfgang J. Parak,
Eduardo Garcia-Rico,
and Ramon A. Alvarez-Puebla
|
| 6643-6643 |
Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype
Correction: Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype |
|
https://doi.org/10.18632/oncotarget.27315
Xiaoqun Dong,
Qiushi Lin,
Arihiro Aihara,
Yu Li,
Chiung-Kuei Huang,
Waihong Chung,
Qi Tang,
Xuesong Chen,
Rolf Carlson,
Christina Nadolny,
Gregory Gabriel,
Mark Olsen,
and Jack R. Wands
|
| 6644-6646 |
